The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance)

IF 6.1 2区 医学 Q1 ONCOLOGY
Cancer Pub Date : 2025-02-24 DOI:10.1002/cncr.35727
Justin C. Brown PhD, Chao Ma MS, Qian Shi PhD, Leonard B. Saltz MD, Anthony F. Shields MD, Jeffrey A. Meyerhardt MD, MPH
{"title":"The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance)","authors":"Justin C. Brown PhD,&nbsp;Chao Ma MS,&nbsp;Qian Shi PhD,&nbsp;Leonard B. Saltz MD,&nbsp;Anthony F. Shields MD,&nbsp;Jeffrey A. Meyerhardt MD, MPH","doi":"10.1002/cncr.35727","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Colon cancer patients have inferior overall survival than a matched general population (MGP). It is unknown if physical activity is associated with a reduction in this survival disparity.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Data were analyzed from two National Cancer Institute–sponsored postoperative treatment trials in stage III colon cancer, Cancer and Leukemia Group B (CALGB) 89803 and 80702, with 2876 patients who self-reported physical activity. Physical activity was converted to metabolic equivalents (MET-hours/week). The MGP was derived from the National Center for Health Statistics and matched on age, sex, and year.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In CALGB 89803, among patients who were alive at 3 years, those with &lt;3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were −17.1% (95% confidence interval [CI], −22.4 to −11.8) and −3.5% (95% CI, −7.7 to 0.3) lower than MGP, respectively. In CALGB 80702, among patients who were alive at 3 years, those with &lt;3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were −10.8% (95% CI, −15.4 to −6.9) and −4.4% (95% CI, −7.6 to −1.6) lower than MGP, respectively. In pooled analyses, among patients who were alive and did not have tumor recurrence by year 3 (<i>n</i> = 1908), those with &lt;3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were −3.1% (95% CI, −6.2 to −0.3) lower and 2.9% (95% CI, 1.5–4.2) higher than MGP, respectively.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Physical activity is associated with an attenuation of the survival disparity between patients with stage III colon cancer participating in clinical trials and MGP. Colon cancer survivors who are physically active may achieve survival that approximates the MGP.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 5","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.35727","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.35727","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Colon cancer patients have inferior overall survival than a matched general population (MGP). It is unknown if physical activity is associated with a reduction in this survival disparity.

Methods

Data were analyzed from two National Cancer Institute–sponsored postoperative treatment trials in stage III colon cancer, Cancer and Leukemia Group B (CALGB) 89803 and 80702, with 2876 patients who self-reported physical activity. Physical activity was converted to metabolic equivalents (MET-hours/week). The MGP was derived from the National Center for Health Statistics and matched on age, sex, and year.

Results

In CALGB 89803, among patients who were alive at 3 years, those with <3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were −17.1% (95% confidence interval [CI], −22.4 to −11.8) and −3.5% (95% CI, −7.7 to 0.3) lower than MGP, respectively. In CALGB 80702, among patients who were alive at 3 years, those with <3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were −10.8% (95% CI, −15.4 to −6.9) and −4.4% (95% CI, −7.6 to −1.6) lower than MGP, respectively. In pooled analyses, among patients who were alive and did not have tumor recurrence by year 3 (n = 1908), those with <3.0 and ≥18.0 MET-hours/week had subsequent 3-year overall survival rates that were −3.1% (95% CI, −6.2 to −0.3) lower and 2.9% (95% CI, 1.5–4.2) higher than MGP, respectively.

Conclusions

Physical activity is associated with an attenuation of the survival disparity between patients with stage III colon cancer participating in clinical trials and MGP. Colon cancer survivors who are physically active may achieve survival that approximates the MGP.

Abstract Image

癌症和白血病B组89803和80702的数据:与匹配的普通人群相比,结肠癌患者体育活动与生存的关系
结肠癌患者的总生存率低于匹配的普通人群(MGP)。目前尚不清楚体育活动是否与这种生存差距的缩小有关。方法分析两项美国国家癌症研究所(National Cancer institute)资助的III期结肠癌、癌症和白血病B组(CALGB) 89803和80702的术后治疗试验的数据,其中2876例患者自我报告了身体活动。体力活动转化为代谢当量(met小时/周)。MGP来自国家卫生统计中心,并根据年龄、性别和年份进行匹配。结果在CALGB 89803中,在3年存活的患者中,每周met -小时数为3.0和≥18.0的患者随后的3年总生存率分别比MGP低- 17.1%(95%可信区间[CI], - 22.4至- 11.8)和- 3.5% (95% CI, - 7.7至0.3)。在CALGB 80702中,在3年存活的患者中,每周met -小时数为3.0和≥18.0的患者随后的3年总生存率分别比MGP低- 10.8% (95% CI, - 15.4至- 6.9)和- 4.4% (95% CI, - 7.6至- 1.6)。在汇总分析中,在存活且到3年没有肿瘤复发的患者中(n = 1908),那些≥18.0 MET-hours/week的患者随后的3年总生存率分别比MGP低3.1% (95% CI, - 6.2至- 0.3)和2.9% (95% CI, 1.5-4.2)。结论:体育活动与参与临床试验的III期结肠癌患者和MGP患者之间的生存差异的衰减有关。经常运动的结肠癌幸存者可能达到接近MGP的存活率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信